Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhitong Li
Institutions:
First Affiliated Hospital of GuangXi Medical University,
Jiangsu Cancer Hospital,
Nanjing Medical University
Observed institutions:
First Affiliated Hospital of GuangXi Medical University,
Jiangsu Cancer Hospital,
Nanjing Medical University
ORCID:
0009-0003-6049-0005
Observed ORCID:
0009-0003-6049-0005
OpenAlex ID:
A5127779332
Decoding Brain Metastasis With Liquid Biopsy: Biomarkers and Technologies in EGFR ‐Mutant NSCLC
2026
·
Yuxiang Sun
, Qinglin Wang
, et al.
·
Cancer Medicine
·
2
Osimertinib plus chemotherapy in epidermal growth factor receptor (EGFR) L858R-mutant non-small cell lung cancer (NSCLC) with an indeterminate transient intracranial lesion: a case report
2026
·
Yuhai Dang
, Xiaojuan Li
, et al.
·
Journal of Medical Case Reports
Figure S6 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S7 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S9 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S3 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S8 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S1 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Table S1 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S2 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S4 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S10 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S5 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Data from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Show more works
View as search
Works count:
14
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type